Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1972 1
1975 1
1976 2
1978 2
1979 1
1980 1
1981 2
1987 1
1992 1
1993 1
1998 2
2000 1
2001 1
2003 1
2004 1
2005 1
2006 1
2007 6
2008 2
2009 7
2010 5
2011 1
2012 2
2013 2
2014 5
2015 2
2016 3
2017 6
2018 2
2019 4
2020 7
2021 5
2022 6
2023 2
2024 7
2025 10

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

98 results

Results by year

Filters applied: . Clear all
Page 1
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, Steinberg WM, Stockner M, Zinman B, Bergenstal RM, Buse JB; LEADER Steering Committee; LEADER Trial Investigators. Marso SP, et al. N Engl J Med. 2016 Jul 28;375(4):311-22. doi: 10.1056/NEJMoa1603827. Epub 2016 Jun 13. N Engl J Med. 2016. PMID: 27295427 Free PMC article. Clinical Trial.
Liraglutide and Renal Outcomes in Type 2 Diabetes.
Mann JFE, Ørsted DD, Brown-Frandsen K, Marso SP, Poulter NR, Rasmussen S, Tornøe K, Zinman B, Buse JB; LEADER Steering Committee and Investigators. Mann JFE, et al. N Engl J Med. 2017 Aug 31;377(9):839-848. doi: 10.1056/NEJMoa1616011. N Engl J Med. 2017. PMID: 28854085 Free article. Clinical Trial.
Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial.
Billings LK, Andreozzi F, Frederiksen M, Gourdy P, Gowda A, Ji L, Pletsch-Borba L, Suzuki R, Unnikrishnan AG, Vianna AGD. Billings LK, et al. Among authors: vianna agd. Lancet Diabetes Endocrinol. 2025 Jul;13(7):556-567. doi: 10.1016/S2213-8587(25)00052-X. Epub 2025 Jun 4. Lancet Diabetes Endocrinol. 2025. PMID: 40482670 Clinical Trial.
Toluene exposure and changes in platelet count: a narrative review.
da Silva GMR, Slawka E, Santos ASE, Vianna ADS. da Silva GMR, et al. Among authors: vianna ads. Rev Bras Med Trab. 2024 Feb 16;21(4):e2021896. doi: 10.47626/1679-4435-2021-896. eCollection 2023 Oct-Dec. Rev Bras Med Trab. 2024. PMID: 39132273 Free PMC article. Review.
Pharmacokinetic/Pharmacodynamic Modeling of Efficacy and Hypoglycemia Rate When Switching From Once-Daily Basal Insulin to Once-Weekly Insulin Icodec Without or With a One-Time Additional Dose in Insulin-Experienced Individuals With Type 2 Diabetes.
Lingvay I, Ásbjörnsdóttir B, Kristensen NR, Laugesen C, Vianna A, Knop FK. Lingvay I, et al. Among authors: vianna a. Endocr Pract. 2025 Feb;31(2):147-151. doi: 10.1016/j.eprac.2024.11.009. Epub 2024 Dec 2. Endocr Pract. 2025. PMID: 39631663 Free article. Clinical Trial.
Time in range: a new parameter to evaluate blood glucose control in patients with diabetes.
Gabbay MAL, Rodacki M, Calliari LE, Vianna AGD, Krakauer M, Pinto MS, Reis JS, Puñales M, Miranda LG, Ramalho AC, Franco DR, Pedrosa HPC. Gabbay MAL, et al. Among authors: vianna agd. Diabetol Metab Syndr. 2020 Mar 16;12:22. doi: 10.1186/s13098-020-00529-z. eCollection 2020. Diabetol Metab Syndr. 2020. PMID: 32190124 Free PMC article. Review.
98 results